Repositorio Dspace

Consensus on early detection of disease progression in patients with multiple sclerosis

Mostrar el registro sencillo del ítem

dc.contributor.author Meca-Lallana, José-Eustasio
dc.contributor.author Casanova, Bonaventura
dc.contributor.author Rodríguez-Antigüedad, Alfredo
dc.contributor.author Eichau, Sara
dc.contributor.author Izquierdo, Guillermo
dc.contributor.author Durán, Carmen
dc.contributor.author Rio, Jordi
dc.contributor.author Hernández, Miguel-Ángel
dc.contributor.author Calles, Carmen
dc.contributor.author Prieto-González, José-M
dc.contributor.author Ara, José-Ramón
dc.contributor.author Uria, Dionisio-F
dc.contributor.author Costa-Frossard, Lucienne
dc.contributor.author García-Merino, Antonio
dc.contributor.author Oreja-Guevara, Celia
dc.date.accessioned 2025-11-21T08:44:14Z
dc.date.available 2025-11-21T08:44:14Z
dc.date.issued 2022-07
dc.identifier.citation Meca-Lallana JE, Casanova B, Rodríguez-Antigüedad A, Eichau S, Izquierdo G, Durán C, et al. Consensus on early detection of disease progression in patients with multiple sclerosis. Front Neurol. 28 de julio de 2022;13:931014.
dc.identifier.issn 1664-2295
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/21940
dc.description.abstract BACKGROUND: Early identification of the transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) can be challenging for clinicians, as diagnostic criteria for SPMS are primarily based on physical disability and a holistic interpretation. OBJECTIVE: To establish a consensus on patient monitoring to identify promptly disease progression and the most useful clinical and paraclinical variables for early identification of disease progression in MS. METHODS: A RAND/UCLA Appropriateness Method was used to establish the level of agreement among a panel of 15 medical experts in MS. Eighty-three items were circulated to the experts for confidential rating of the grade of agreement and recommendation. Consensus was defined when ?66% agreement or disagreement was achieved. RESULTS: Consensus was reached in 72 out of 83 items (86.7%). The items addressed frequency of follow-up visits, definition of progression, identification of clinical, cognitive, and radiological assessments as variables of suspected or confirmed SPMS diagnosis, the need for more accurate assessment tools, and the use of promising molecular and imaging biomarkers to predict disease progression and/or diagnose SPMS. CONCLUSION: Consensus achieved on these topics could guide neurologists to identify earlier disease progression and to plan targeted clinical and therapeutic interventions during the earliest stages of SPMS.
dc.language.iso eng
dc.publisher FRONTIERS MEDIA SA
dc.rights Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/4.0/es/  *
dc.title Consensus on early detection of disease progression in patients with multiple sclerosis
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 35968319
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fneur.2022.931014/full
dc.identifier.doi 10.3389/fneur.2022.931014
dc.journal.title Frontiers in Neurology


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta